| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cachexia | FAERS: 2 | US FAERS | |
| 2 | Hypersensitivity | FAERS: 2 | US FAERS | |
| 3 | Malaise | FAERS: 2 | US FAERS | |
| 4 | Myocardial Infarction | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Occupational exposure to product | FAERS: 2 | US FAERS | |
| 6 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 7 | Colitis | FAERS: 1 | US FAERS | |
| 8 | Hepatitis | FAERS: 1 | US FAERS | |
| 9 | Malaria | FAERS: 1 | US FAERS | |
| 10 | Myalgia | FAERS: 1 | US FAERS | |
| 11 | Poisoning | FAERS: 1 | US FAERS | |
| 12 | Pruritus | FAERS: 1 | US FAERS | |
| 13 | Rubella | FAERS: 1 | US FAERS | |
| 14 | Stomatitis | FAERS: 1 | US FAERS | |
| 15 | Weight decreased | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.